Tesaro, Inc. (NASDAQ:TSRO) Analyst Ratings as of May 17, 2018

May 17, 2018 - By Nicole Mills

Tesaro, Inc. (NASDAQ:TSRO) Corporate Logo
Big Money Sentiment decreased to 1.01 in 2017 Q4. It has change of 0.20, from 2017Q3’s 1.21. The ratio dropped due to Tesaro, Inc. positioning: 46 sold and 64 reduced. 39 funds amassed positions and 72 increased positions. Investors holded 58.28 million in 2017Q3 but now own 57.95 million shares or 0.57% less.
Us Retail Bank De, Minnesota-based fund reported 197 shs. Tekla Llc, Massachusetts-based fund reported 57,595 shs. Moreover, Rhumbline Advisers has 0.01% invested in Tesaro, Inc. (NASDAQ:TSRO) for 39,477 shs. Voya Mngmt Ltd Liability Co invested 0% in Tesaro, Inc. (NASDAQ:TSRO). Strs Ohio holds 0% of its capital in Tesaro, Inc. (NASDAQ:TSRO) for 492 shs. Advsr Asset Mgmt holds 0% or 2,177 shs in its capital. Hsbc Hldgs Public Llc accumulated 15,114 shs. Fjarde Ap invested 0.02% in Tesaro, Inc. (NASDAQ:TSRO). Credit Suisse Ag has 268,936 shs for 0.02% of their capital. Ameriprise Incorporated holds 1.27 million shs or 0.05% of its capital. Jennison Ltd Liability has invested 0.03% in Tesaro, Inc. (NASDAQ:TSRO). Rock Springs Capital Mngmt L P owns 548,500 shs for 2.06% of their capital. Federated Invsts Pa holds 0.07% or 305,482 shs. Dimensional Fund Advsr L P, Texas-based fund reported 83,359 shs. Qs Invsts Llc holds 1,206 shs or 0% of its capital.

Tesaro, Inc. had 7 insider sales and 9 buys since March 1, 2018. This’s net activity of $61.19 million. $141,265 worth of Tesaro, Inc. (NASDAQ:TSRO) shs were sold by PEARSON TIMOTHY R. On Friday, March 2 the insider KERINS PATRICK J bought $6.68M. On Thursday, March 1 the insider Oliveira Orlando sold $18,488. Another trade for 145,532 shs valued at $8.35M was bought by Viswanathan Ravi. On Thursday, March 1 Farmer Joseph L sold $144,501 worth of Tesaro, Inc. (NASDAQ:TSRO) or 2,634 shs. On Friday, March 2 $8.35 million worth of Tesaro, Inc. (NASDAQ:TSRO) was bought by SANDELL SCOTT D.

Tesaro, Inc. (NASDAQ:TSRO) Ratings Coverage

In total 15 analysts cover Tesaro (NASDAQ:TSRO). “Buy” rating has 12, “Sell” are 0, while 3 are “Hold”. (NASDAQ:TSRO) has 80% bullish analysts. 18 are the (NASDAQ:TSRO)’s ratings reports on May 17, 2018 according to StockzIntelligence Inc. On Tuesday, March 27 Wedbush maintained Tesaro, Inc. (NASDAQ:TSRO) with “Buy” rating. On Thursday, February 22 the firm has “Outperform” rating given by Evercore. The company rating was maintained by Lake Street on Monday, May 7. On Wednesday, May 2 Argus Research maintained Tesaro, Inc. (NASDAQ:TSRO) with “Buy” rating. In Wednesday, January 3 report Guggenheim maintained it with “Buy” rating and $125.0 target. On Friday, May 4 the stock has “Buy” rating by H.C. Wainwright. In Wednesday, February 28 report Wells Fargo maintained the stock with “Buy” rating. On Friday, May 4 Citigroup maintained Tesaro, Inc. (NASDAQ:TSRO) with “Buy” rating. On Friday, May 4 Credit Suisse maintained Tesaro, Inc. (NASDAQ:TSRO) with “Outperform” rating. On Thursday, January 18 the firm has “Hold” rating given by Piper Jaffray. Listed here are Tesaro, Inc. (NASDAQ:TSRO) PTs and latest ratings.

07/05/2018 Broker: Lake Street Rating: Buy New Target: $80.0000 Maintain
04/05/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $94 New Target: $88 Maintain
04/05/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $141 New Target: $128 Maintain
04/05/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $102 New Target: $100 Maintain
04/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $104.0000 Maintain
02/05/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $154 New Target: $110 Maintain
16/04/2018 Broker: Piper Jaffray Rating: Hold Maintain
27/03/2018 Broker: Wedbush Rating: Buy New Target: $76.0000 Maintain
28/02/2018 Broker: Cowen & Co Rating: Hold New Target: $66.0 Maintain
01/03/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $156 New Target: $146 Maintain

TSRO is hitting $50.58 during the last trading session, after increased 3.47%.Tesaro, Inc. has volume of 673,653 shares. Since May 17, 2017 TSRO has declined 63.82% and is downtrending. TSRO underperformed by 75.37% the S&P500.

Tesaro, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States.The firm is worth $2.77 billion. It markets Rolapitant, a neurokinin-1, or NK-1, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting under the VARUBI brand name.Last it reported negative earnings. The firm is also developing Niraparib, an orally active and potent poly polymerase inhibitor, which is in various clinical trials to treat ovarian or breast cancers.

A couple more Tesaro, Inc. (NASDAQ:TSRO) news were released by: Globenewswire.com which released on May 01, 2018 “TESARO Announces Participation in Two Investor Conferences”, also Globenewswire.com on May 03, 2018 released “TESARO Announces First-Quarter 2018 Operating Results”, the next Streetinsider.com is “TESARO (TSRO) Announces Presentations of Abstracts at ASCO” on May 16, 2018. Nasdaq.com has article titled “TESARO Announces Presentations of Abstracts at the 2018 American Society of Clinical Oncology (ASCO) Annual …”.

Tesaro, Inc. (NASDAQ:TSRO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.